In Re Pacific Fertility Center Litigation

District Court, N.D. California·Decided March 5, 2021·No. 3:18-cv-01586·Unknown

Opinion

IN RE PACIFIC FERTILITY CENTER Case No. 18-cv-01586-JSC

ORDER RE: CHART’S MOTIONS TO EXCLUDE PLAINTIFFS’ EXPERTS Dkt. Nos. 629, 631

Plaintiffs bring product liability and failure to recall claims against Chart Industries following a March 2018 incident involving a Chart-manufactured cryopreservation tank which was storing Plaintiffs’ eggs and embryos. In connection with summary judgment and in preparation for trial, the parties have each filed motions to exclude the other’s expert testimony in whole or in part under the Federal Rules of Evidence and Daubert v. Merrell Dow Pharm., Inc., 509 U.S. 579 (1993).1 (Dkt. Nos. 629, 631, 632. 2) This Order focuses on Chart’s motions to exclude Plaintiffs’ experts Dr. Kasbekar, Dr. Wininger, and Dr. Grill. Having considered the parties’ briefing regarding these motions and having had the benefit of oral argument on March 4, 2021, Chart’s motions are DENIED for the reasons set forth below. // 1 All parties have consented to the jurisdiction of a magistrate judge pursuant to 28 U.S.C. § 636(c). (Dkt. No. 553.) Plaintiffs obtained fertility services from Pacific Fertility Center (PFC)3, and in particular, as relevant here, cryopreservation of their eggs and embryos. On March 4, 2018, PFC’s laboratory director, Dr. Joseph Conaghan, discovered that Tank 4 which contained 2,500 embryos and 1,500 eggs—including Plaintiffs’ eggs and embryos—had lost liquid nitrogen. As a result of this incident, Plaintiffs filed the underlying action against Chart alleging manufacturing and design defects, as well as negligent failure to recall.4 Chart denies any liability and insists that the Tank 4 incident occurred because of PFC’s negligence. Over 130 individual actions alleging these same claims against Chart have been consolidated with the Plaintiffs’ claims here. The claims of the five original Plaintiffs, A.B., C.D., E.F., G.H., and I.J. are scheduled for trial May 3, 2021. Under Rule 702 of the Federal Rules of Evidence, a witness may offer expert testimony if the following requirements are met:

(a) the expert’s scientific, technical, or other specialized knowledge will help the trier of fact to understand the evidence or to determine a fact in issue;

(b) the testimony is based on sufficient facts or data;

(c) the testimony is the product of reliable principles and methods; and (d) the expert has reliably applied the principles and methods to the facts of the case. Fed. R. Evid. 702. These criteria can be distilled to two overarching considerations: “reliability and relevance.” Ellis v. Costco Wholesale Corp., 657 F.3d 970, 982 (9th Cir. 2011). The inquiry does not, however, “require a court to admit or exclude evidence based on its persuasiveness.” Id. Scientific evidence is reliable “if the principles and methodology used by an expert are

Free access — add to your briefcase to read the full text and ask questions with AI

In Re Pacific Fertility Center Litigation, (N.D. Cal. 2021).

In Re Pacific Fertility Center Litigation (In Re Pacific Fertility Center Litigation) — published by Counsel Stack Legal Research, free access to 12M+ legal documents.

Related

Primiano v. Cook
598 F.3d 558 (Ninth Circuit, 2010)
Daubert v. Merrell Dow Pharmaceuticals, Inc.
509 U.S. 579 (Supreme Court, 1993)
Ellis v. Costco Wholesale Corp.
657 F.3d 970 (Ninth Circuit, 2011)
United States v. Richard Joseph Finley
301 F.3d 1000 (Ninth Circuit, 2002)
Schipp Ex Rel. Estate of Neufelder v. General Motors Corp.
443 F. Supp. 2d 1023 (E.D. Arkansas, 2006)
City of Pomona v. Sqm North America Corporation
750 F.3d 1036 (Ninth Circuit, 2014)
Stephen Wendell v. Glaxosmithkline LLC
858 F.3d 1227 (Ninth Circuit, 2017)
Demara v. Raymond Corp.
221 Cal. Rptr. 3d 102 (California Court of Appeals, 5th District, 2017)
Daubert v. Merrell Dow Pharmaceuticals, Inc.
43 F.3d 1311 (Ninth Circuit, 1995)
In re Roundup Prods. Liab. Litig.
390 F. Supp. 3d 1102 (N.D. California, 2018)
Clausen v. M/V New Carissa
339 F.3d 1049 (Ninth Circuit, 2003)